Factor I is required for the development of membranoproliferative glomerulonephritis in factor H-deficient mice

Kirsten L Rose1, Danielle Paixao-Cavalcante, Jennifer Fish

  • 1Molecular Genetics and Rheumatology Section, Faculty of Medicine, Imperial College, Hammersmith Campus, London, United Kingdom.

Insights

Factor I is crucial for developing membranoproliferative glomerulonephritis type II (MPGN2) in factor H-deficient individuals. This kidney disease involves complement C3 deposition, and factor I drives its formation in the circulation.

Area of Science:

  • Nephrology
  • Immunology
  • Complement System Biology

Background:

  • Membranoproliferative glomerulonephritis type II (MPGN2) is an inflammatory kidney disease linked to complement alternative pathway dysregulation.
  • MPGN2 features complement C3 deposition along the glomerular basement membrane (GBM).
  • Factor H and Factor I are key regulators of C3 spontaneous activation via the alternative pathway.

Purpose of the Study:

  • To investigate the discordance in MPGN2 development between factor H and factor I deficiencies.
  • To elucidate the role of factor I in C3 deposition and MPGN2 pathogenesis.

Main Methods:

  • Studied mice with single or combined deficiencies of factor H and factor I.
  • Administered factor I to mice with combined factor H and I deficiency.
  • Utilized mouse renal transplant models to trace C3 deposition origins.

Main Results:

  • MPGN2 did not develop in mice deficient in factor I alone or in combined factor H and I deficiency.
  • Factor I administration to factor H/I deficient mice induced plasma C3 fragments and GBM C3 deposition.
  • Renal transplant studies confirmed plasma origin of GBM-deposited C3.

Conclusions:

  • Factor I-mediated generation of activated C3 fragments in circulation is critical for MPGN2 development in factor H deficiency.
  • This study provides the first evidence linking factor I activity to MPGN2 pathogenesis in factor H deficiency.